US boost for cannabis-based epilepsy medicine

April 14, 2015 7:27 AM

18 0

Cambridge based GW Pharmaceuticals, which is commercialising cannabis-based medicines across a broad disease range on both sides of the Atlantic, has received a boost in the US.

It came in the form of encouraging data on GW’s investigational medicine Epidiolex issued by the American Academy of Neurology (AAN).

Read more

To category page